Innate Pharma (IPHYF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 12-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,783 | 60,965 | 71,847 | 76,416 | 77,870 |
| Marketable Securities | 7,035 | 7,178 | 15,554 | 23,649 | 19,055 |
| Receivables | 14,029 | 5,620 | 5,380 | 60,129 | 60,589 |
| Other current assets | 1 | 0 | 0 | -1 | 0 |
| TOTAL | $52,848 | $73,763 | $92,781 | $160,193 | $157,514 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,625 | N/A | N/A | N/A |
| Other Non-Current Assets | 13,184 | 26,113 | 21,841 | 32,316 | 51,613 |
| TOTAL | $13,184 | $31,738 | $21,841 | $32,316 | $51,613 |
| Total Assets | $70,960 | $105,502 | $120,177 | $199,352 | $217,043 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,019 | 13,669 | 17,321 | 18,419 | 20,708 |
| Other current liabilities | 24,446 | 19,096 | 18,369 | 24,481 | 20,364 |
| TOTAL | $41,465 | $33,404 | $35,690 | $42,899 | $41,072 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 639 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 54,052 | 63,275 | 71,871 | 85,535 | 95,812 |
| TOTAL | $54,052 | $66,258 | $74,928 | $100,280 | $112,875 |
| Total Liabilities | $95,516 | $99,663 | $110,618 | $143,180 | $153,948 |
| Shareholders' Equity | |||||
| Common Shares | 5,303 | 5,233 | 4,536 | 4,377 | 4,391 |
| Retained earnings | -437,133 | -438,600 | -364,552 | -356,426 | -360,176 |
| Other shareholders' equity | -54,375 | -22,874 | -53,503 | -7,658 | 3,032 |
| TOTAL | $-24,556 | $5,840 | $9,559 | $56,172 | $63,094 |
| Total Liabilities And Equity | $70,960 | $105,502 | $120,177 | $199,352 | $217,042 |